Discover 1,057 paid clinical trials in Provo, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,057
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
for
Heterozygous or Homozygous Familial Hypercholesterolemia
Location: Salt Lake City UT
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 70+
Code: NCT05682378
Phase 3, Recruiting
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment
for
Homocystinuria
Location: Salt Lake City UT, Phoenix AZ, Dallas TX, Chicago IL,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 12 - 65
Code: NCT06247085
Phase 3, Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
for
Congenital Diaphragmatic Hernia
Location: Salt Lake City UT, Aurora CO, Los Angeles CA, Irvine CA,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT05213676
Recruiting
A Novel mHealth Intervention to Improve Outcomes of Children With Medical Complexity
for
Children With Medical Complexity
Location: Salt Lake City UT, Chicago IL
Sponsor: University of Utah
Sex: All
Age: 1 - 18
Code: NCT06883045
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Salt Lake City UT, Aurora CO, Oakland CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 2 - 18
Code: NCT05711667
Phase 3, Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Salt Lake City UT, Aurora CO, Phoenix AZ,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase 1, Phase 2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Salt Lake City UT, Denver CO, Aurora CO, Reno NV,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase 3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Salt Lake City UT, Minneapolis MN, Little Rock AR,
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 0 - 17
Code: NCT06994442
Phase 3, Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Salt Lake City UT, Aurora CO, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT06941272
Phase 1, Phase 2, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Salt Lake City UT, Boise ID, Las Vegas NV, Denver CO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Salt Lake City UT, Boise ID, Las Vegas NV, Aurora CO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Salt Lake City UT, Las Vegas NV, Denver CO, Aurora CO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
Stress Hydrocortisone In Pediatric Septic Shock
for
Septic Shock
Location: Salt Lake City UT, Tucson AZ, Los Angeles CA, Orange CA,
Sponsor: Jerry Zimmerman
Sex: All
Age: 0 - 17
Code: NCT03401398
Phase 3, Recruiting
Comparison of Uncomplicated Candidemia Therapy Duration in Children
for
Invasive Candidiasis
Location: Salt Lake City UT, Orange CA, Omaha NE, Dallas TX,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0+
Code: NCT05763251
Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
for
Rheumatic Joint Disease
Location: Salt Lake City UT, Aurora CO, Phoenix AZ,